“I want to turn innovative research into new drugs”
Each year some 250,000 patients develop a type of cancer because of faulty communication between cells. This malfunction occurs in what is known as the…
clement04.07.2017
“Ideally new projects are addressing an important and unmet medical need”
We interviewed Trudi Haemmerli, CEO and Director at PerioC Ltd, Managing Director of TruStep Consulting GmbH, and member of our selection committee, on her view…
clement20.04.2017
“Projects are expected to be game changing”
We interviewed Dr. Nathalie ter Wengel MD, European Head Global External R&D and Innovation at Pfizer, and member of our selection committee, on her view…
clement20.04.2017
“We look for individuals who challenge the status quo”
We interviewed Dr. Fabian Buller, Director of New Ventures at Johnson & Johnson Innovation, and member of our selection committee, on his view of the…
clement20.04.2017
